Study points to FDA-approved drugs that have potential to slow or reverse brain damage
New Alzheimer’s treatment targets identified (Links to an external site)
Category: Research
Laughing gas relieves symptoms in people with treatment-resistant depression (Links to an external site)
Single treatment provides patients with rapid, lasting antidepressant effects
Alcohol problems severely undertreated (Links to an external site)
Heavy drinkers see doctors regularly, but few receive treatment for disorder
WashU, Pitt awarded $10.7 million for Alzheimer’s disease research (Links to an external site)
Study to look for genetic pathways that lead to formation of plaques, tangles
Mice That Hear Imaginary Sounds May Help Explain Hallucinations In People (Links to an external site)
A technique that induces imaginary sounds in both mice and people could help scientists understand the brain circuits involved in schizophrenia and other disorders that cause hallucinations.
Washington University researchers to design detectors of airborne SARS-CoV-2 (Links to an external site)
Alzheimer’s researchers, aerosol engineer team up to develop rapid screening tools
Finding a possible early treatment for COVID-19 in a 40-year-old antidepressant (Links to an external site)
Sharyn Alfonsi reports on the unusual path fluvoxamine, a drug commonly used to treat obsessive-compulsive disorder, has had to becoming an early treatment candidate for COVID-19
Opioid overdose reduced in patients taking buprenorphine (Links to an external site)
Study indicates the drug is effective in opioid users who also take benzodiazepines for anxiety, other conditions
Young people with disabilities focus of COVID-19 testing grant (Links to an external site)
$5 million grant to fund saliva tests for students, teachers, staff in schools operated by Special School District of St. Louis County
Fluvoxamine may prevent serious illness in COVID-19 patients (Links to an external site)
Antidepressant drug repurposed for patients with coronavirus infection